Neudle.com: "Jehovah's witness"

Differential
(Click to cross reference)

acquired immunodeficiency syndrome

activated protein C resistance

addiction, heroin

advances in neurology

anticardiolipin antibodies

anticoagulant, treatment

antiphospholipid antibodies

antithrombin III deficiency

blood dyscrasias, neurologic findings with

calcitonin gene related peptide

calcitonin gene-related peptide receptor blocker

carbenoxolone

cardiac arrest

cardiac arrest and resuscitation

cardiomyopathy

CAT scan

CAT scan, abnormal

CAT scan, delta sign, empty

CAT scan, venography

cerebral infarction

cerebral ischemia

cerebral venous infarction

cerebral venous thrombosis

cerebral venous thrombosis, deep

cerebral venous thrombosis, etiology

cerebral venous thrombosis, recurrent

cerebrovascular accident

cerebrovascular accident, acute management of

cerebrovascular accident, age of lesion

cerebrovascular accident, awakening with

cerebrovascular accident, cost of

cerebrovascular accident, familial occurrence

cerebrovascular accident, infancy and childhood

cerebrovascular accident, prevention of

cerebrovascular accident, recurrent

cerebrovascular accident, thrombolytic agents in treatment

cerebrovascular accident, time of onset

cerebrovascular accident, time to treatment

cerebrovascular accident, unknown time of onset

cerebrovascular accident, women

cerebrovascular accident, work up for

cerebrovascular accident, young adult

cerebrovascular disease, risk factors in

cerebrovascular disease, treatment of

craniectomy, decompressive

D-dimer

dipyridamole

disseminated intravascular coagulation(DIC)

diuretic

drug induced neurologic disorders

dural sinus thrombosis

efficacy

electrocardiogram, abnormal

embolism, platelet

endovascular therapy

enolase

enzyme, muscle disease

epidemiology of neurology

epsilon-aminocaproic acid(E.A.C.A.)

erenumab

evidence-based research

fibrinolytic agents, intra-venous local infusion

fibrinolytic therapy, selection criteria

fibrinolytic therapy, timing of administration

genetic neurologic disorders

genetic testing

head injury

head injury, pediatric

hemoglobin abnormality, neurologic complications of

human immunodeficiency virus type 1

hydrocephalus

hypercholesterolemia

hypokalemia

hypoxic encephalopathy

incidence

infantile hemiplegia

interobserver agreement

intracerebral hemorrhage

intracranial hypertension, benign

intracranial pressure, increased

ipecac

Jehovah's witness

leukemia

leukemia, neurologic findings assoc.with

level of consciousness, decreased

middle cerebral artery territory infarction

middle cerebral artery, occlusion of

migraine

migraine, chronic

migraine, prophylaxis

migraine, treatment of

misdiagnosis

monoclonal antibodies

MRI, CAT scan compared to

MRI, contrast enhanced

MRI, diffusion weighted

MRI, false negative

MRI, mismatch between DWI/FLAIR

muscle weakness, causes of

myeloproliferative disorder

myopathy, drug-induced

myopathy, hypokalemic

myopathy, proximal

myopathy, steroid induced

nausea and vomiting

neurologic complications of, systemic disease

neurologic disease, diagnoses of

neurologic examination, focal

neuron specific enolase

nonsteroidal anti-inflammatory drug

oral contraceptives

oral contraceptives, cerbrovascular disease and

oral contraceptives, neurologic complications with

paroxysmal nocturnal hemoglobinuria

patient selection

perhexiline maleate

pitfalls

plasminogen deficiency

platelet inhibiting drugs

polycythemia, primary

practice guidelines

pregnancy, neurologic complications in

prethrombotic state

prevention of neurologic disorders

primary thrombocythemia

superior sagittal sinus thrombosis

thrombocytopenia

thrombophlebitis

tissue plasminogen activator, intravenous

transient ischemic attack

transient ischemic attack, treatment of

treatment of neurologic disorder

triglycerides

vincristine neurotoxicity

visual loss

visual loss, sudden

workup

Showing articles 0 to 32 of 32

A Teenager with Persistent Headache
Neurol 92:e1526-e1531, Hu, Y.,et al, 2019

Fremanezumab versus Placebo for Migraine Prevention in Patients with Documented Failure to Up to Four Migraine Preventive Medication Classes (FOCUS): A Randomised, Double-Blind, Placebo-Controlled, Phase 3� Trial
Lancet 394:1030-1040, Ferrari, M.D.,et al, 2019

Targeting Calcitonin Gene-Related Peptide: A New Era in Migraine Therapy
Lancet 394:1765-1774, Charles, A. & Pozo-Rosich, P., 2019

Intravenous Thrombolysis in Unwitnessed Stroke Onset: MR WITNESS Trial Results
Ann Neurol 83:980-993, Schwamm, L.H.,et al, 2018

Preventive Migraine Drug Approved
JAMA 320:1746, , 2018

CGRP - The Next Frontier for Migraine
NEJM 377:2190-2191, Hershey, A.D., 2017

Profound Anemia and Acute Blindness in a Jehovahs Witness
Lancet 382:998, Bretagnol, A.,et al, 2013

Diagnosis and Management of Cerebral Venous Thrombosis: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:1158-1192, Saposnik,G.,et al, 2011

Protein S Deficiency in HIV Associated Ischaemic Stroke:An Epiphenomenon of HIV Infection
JNNP 76:1455-1456,1331, Mochan,A.,et al, 2005

Use of Specialized Coagulation Testing in the Evaluation of Patients with Acute Ischemic Stroke
Neurol 56:624-627, Bushnell,C.,et al, 2001

Prethrombotic Disorders in Children with Arterial Ischemic Stroke and Sinovenous Thrombosis
Arch Neurol 56:967-971, Bonduel,M.,et al, 1999

Risk of Cerebral Sinus Thrombosis in Oral Contraceptive Users Who Are Carriers of Hered Prothrombotic Cond
BMJ 316:589-592, deBruijn,S.F.T.M.,et al, 1998

Neurology and the Blood:Haematological Abnormalities in Ischaemic Stroke
JNNP 64:150-159, Markus,H.S.&Hambley,H., 1998

Serum S-100 and Neuron-Specific Enolase for Prediction of Regaining Consciousness After Global Cerebral Ischemia
Stroke 29:2363-2366, Martens,P.,et al, 1998

Inherited Prothrombotic States and Ischaemic Stroke in Childhood
JNNP 65:508-511, Ganesan,V.,et al, 1998

Human Immunodeficiency Virus Infection and Stroke in Young Patients
Arch Neurol 54:1150-1153, Qureshi,A.I.,et al, 1997

Cerebral Venous Thrombosis in Adults:A Study of 40 Cases From Saudi Arabia
Stroke 26:1193-1195, Daif,A.,et al, 1995

Prothrombotic States in Young People with Idiopathic Stroke:Prospective Study
Stroke 25:287-290, Baringarrementeria,F., 1994

Ischemic Stroke Due to Deficiency of Coagulation Inhibitors, Report of 10 Young Adults
Stroke 24:19-25, Martinez,H.R.,et al, 1993

Free Protein S Deficiency in Acute Ischemic Stroke, A Case-Control Study
Stroke 24:224-227, Mayer,S.A.,et al, 1993

An Unusual Cause of Cerebral Venous Thrombosis in a Four-Year-Old Child
Stroke 24:603-605, Rich,C.,et al, 1993

Protein S Deficiency in Middle-Aged Women with Stroke
Neurol 42:1029-1033, Green,D.,et al, 1992

Superior Sagittal Sinus Thrombosis in a Child with Protein S Deficiency
Neurol 42:2303-2305, Prats,J.M.,et al, 1992

Superior Sagittal Sinus Thrombosis in a Patient with Protein S Deficiency
Stroke 21:633-636, Cros,D.,et al, 1990

Hematologic Disorders and Ischemic Stroke
Stroke 21:1111-1121, Hart,R.G.&Kanter,M.C., 1990

Childhood Stroke Associated with Protein C or S Deficiency
J Pediatr 111:562-564, Israels,S.J.&Seshia,S.S., 1987

Drug-Induced Myopathies In Man
Lancet 2:562-566, Lane,R.J.M.,et al, 1978

Clofibrate-Induced Muscle Damage with Myoglobinuria & Cardiomyopathy
NEJM 296:942, Smals,A.G.H., 1977

Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease
NEJM 293:174, Genton,E.,et al, 1975

The Treatment of Cerebrovascular Disease with Clofibrate
VA Cooperative Study Group, Stroke 4:6841973., , 1973

Muscular Syndrome after Clofibrate
NEJM 286:1110, Katsilambros,N., 1972

Clofibrate for the Treatment of Occlusive CVD-Correspondence
NEJM 287:671, Hirsch,S.,et al, 1972

Showing articles 0 to 32 of 32